Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load
British Journal of Cancer. 1998;78(1):69-72 
Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer
The Prostate. 1996;28(5):318-324
The Relationship between p53 Expression and Human Papillomavirus in Premalignant and Malignant Uterine Cervical Lesions
Open Journal of Pathology. 2016;06(02):73-78
The effects of wild type p53 tumor suppressor gene expression on the normal human cervical epithelial cells or human epidermal keratinocytes transformed with human papillomavirus type 16 DNA
Yonsei Medical Journal. 1995;36(3):287
Human papillomavirus type 16/18 in uterine cervical adenocarcinomain situ and adenocarcinoma a study byin situ hybridization with biotinylated DNA probes
Cancer. 1990;65(11):2588-2593
Differential expression of p53 and p21 in low grade cervical squamous intraepithelial lesions infected with low, intermediate, and high risk human papillomaviruses
Cancer. 2000;89(6):1300-1307
Two Distinct Human Uterine Cervical Epithelial Cell Lines Established after Transfection with Human Papillomavirus 16 DNA
Japanese Journal of Cancer Research. 1997;88(7):644-651
Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection
Papillomavirus Research. 2020;9:100193
Does p53 expression correlate with p21 expression in cancer of the uterine corpus?
The Journal of Pathology. 2000;191(3):341-342
Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma
Cancer Detection and Prevention. 2005;29(6):528-536